Aligos Therapeutics vs Camp4 Therapeutics
Camp4 Therapeutics is the larger business, with $3.5m of revenue in fiscal 2025 against $2.2m for Aligos Therapeutics (1.6 times as much). Camp4 Therapeutics grew faster (436.5% against -39.5%). Aligos Therapeutics kept more of each dollar of sales as profit: a net margin of -1106.7% against -2298.5%.
| Latest fiscal year | Aligos TherapeuticsALGS, 2025 | Camp4 TherapeuticsCAMP, 2025 |
|---|---|---|
| Revenue | $2.2m | $3.5m |
| Revenue growth | -39.5% | 436.5% |
| Net income | −$24.2m | −$80.4m |
| Operating margin | — | -1502.4% |
| Net margin | -1106.7% | -2298.5% |
| Return on equity | -196.9% | -145.1% |
| Free cash flow | −$82.5m | −$29.8m |
| Cash | $18.3m | $110m |
| Total debt | $0 | $0 |
| Debt to equity | — | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 82 | 48 |
| Market value | $29.6m | $201m |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 0 buys, 0 sales | 5 buys, 6 sales |